bluebird bio, Inc. financial data

Symbol
BLUE on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
455 Grand Union Boulevard, Somerville, MA
State of incorporation
DE
Fiscal year end
December 31
Former names
Genetix Pharmaceuticals Inc (to 3/19/2010)
Latest financial report
10-Q - Q1 2024 - Sep 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 138 % -14.2%
Quick Ratio 11.2 %
Debt-to-equity 202 % +0.92%
Return On Equity -144 % -207%
Return On Assets -47.6 % -214%
Operating Margin -730 % +75.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 194M shares +77.4%
Common Stock, Shares, Outstanding 194M shares +82%
Entity Public Float 346M USD +14.6%
Common Stock, Value, Issued 1.91M USD +79.8%
Weighted Average Number of Shares Outstanding, Basic 193M shares +87.7%
Weighted Average Number of Shares Outstanding, Diluted 193M shares +87%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 45.7M USD +1033%
Revenue from Contract with Customer, Excluding Assessed Tax 18.6M USD +708%
Cost of Revenue 53.9M USD +640%
Research and Development Expense 151M USD -7.93%
Costs and Expenses 326M USD +4.74%
Operating Income (Loss) -334M USD -180%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -91.1M USD +78.9%
Income Tax Expense (Benefit) -126K USD -208%
Net Income (Loss) Attributable to Parent -301M USD -237%
Earnings Per Share, Basic -2.47 USD/shares -127%
Earnings Per Share, Diluted -2.47 USD/shares +10.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 212M USD -11.3%
Marketable Securities, Current 0 USD -100%
Inventory, Net 30.3M USD +696%
Other Assets, Current 17.4M USD
Assets, Current 272M USD -22.6%
Property, Plant and Equipment, Net 90.4M USD +937%
Operating Lease, Right-of-Use Asset 195M USD -27.7%
Intangible Assets, Net (Excluding Goodwill) 10.2M USD +82.5%
Goodwill 5.65M USD 0%
Other Assets, Noncurrent 58.4M USD +13.4%
Assets 631M USD -8.84%
Accounts Payable, Current 19.4M USD +0.79%
Employee-related Liabilities, Current 10.9M USD +17.1%
Contract with Customer, Liability, Current 9.65M USD +517%
Liabilities, Current 294M USD +153%
Operating Lease, Liability, Noncurrent 181M USD -18.6%
Other Liabilities, Noncurrent 92K USD 0%
Liabilities 500M USD +48.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.11M USD +31.7%
Retained Earnings (Accumulated Deficit) -4.33B USD -9.2%
Stockholders' Equity Attributable to Parent 131M USD -54.9%
Liabilities and Equity 631M USD -8.84%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -74.7M USD -4.65%
Net Cash Provided by (Used in) Financing Activities 64.6M USD -43.9%
Net Cash Provided by (Used in) Investing Activities -655K USD -101%
Common Stock, Shares Authorized 250M shares +100%
Common Stock, Shares, Issued 194M shares +82%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -10.7M USD -108%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 264M USD -7.2%
Deferred Tax Assets, Valuation Allowance 1.19B USD +6.55%
Deferred Tax Assets, Gross 1.26B USD +5.51%
Operating Lease, Liability 205M USD
Payments to Acquire Property, Plant, and Equipment 1.78M USD +665%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -300M USD -241%
Lessee, Operating Lease, Liability, to be Paid 258M USD
Property, Plant and Equipment, Gross 27.1M USD -22.9%
Operating Lease, Liability, Current 24.4M USD -52.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 35.7M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 37.1M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 52.8M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 36.7M USD
Deferred Tax Assets, Operating Loss Carryforwards 726M USD +1.75%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 24.5M USD +4.45%
Lessee, Operating Lease, Liability, to be Paid, Year Four 37.8M USD
Operating Lease, Payments 2.84M USD -55.3%
Additional Paid in Capital 4.46B USD +3.22%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 17.8M USD -36.6%
Interest Expense 4.86M USD +13.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%